The Administration, Evaluation and Planning Core (Core A;Dr. Robert Clarke, Core Director) is critical to the success of this CCSB. The primary purpose of Core A is to coordinate CCSB activities and to provide the oversight and leadership of all scientific, educational, administrative, financial, and planning aspects of the CCSB. Activities within Core A will ensure the full integration of the various scientific disciplines into the multidisciplinary approaches we propose for advancing research in the field of cancer systems biology, and its ultimate translation into the clinical setting. More broadly, the administrative functions are responsible for ensuring compliance with all general, institutional, federal, and NCI/ICBP requirements and regulations, which include the timely and effective coordination of communication and consultation within the CCSB, with the appropriate NCI/ICBP staff, the ICBP Steering Committee, and with all other ICBP CCSBs. Core A is also responsible for convening all meetings of the CCSB including those of the Internal Advisory Committee (lAC;membership and functions described below) and External Advisory Committee (EAC).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA149147-04
Application #
8517450
Study Section
Special Emphasis Panel (ZCA1-SRLB-C)
Project Start
Project End
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
4
Fiscal Year
2013
Total Cost
$92,695
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Little, J L; Serzhanova, V; Izumchenko, E et al. (2014) A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice. Oncogene 33:411-20
Chen, Chun; Baumann, William T; Xing, Jianhua et al. (2014) Mathematical models of the transitions between endocrine therapy responsive and resistant states in breast cancer. J R Soc Interface 11:20140206
Hatzis, Christos; Bedard, Philippe L; Birkbak, Nicolai J et al. (2014) Enhancing reproducibility in cancer drug screening: how do we move forward? Cancer Res 74:4016-23
Tian, Ye; Zhang, Bai; Hoffman, Eric P et al. (2014) Knowledge-fused differential dependency network models for detecting significant rewiring in biological networks. BMC Syst Biol 8:87
Chen, Li; Choyke, Peter L; Wang, Niya et al. (2014) Unsupervised deconvolution of dynamic imaging reveals intratumor vascular heterogeneity and repopulation dynamics. PLoS One 9:e112143
Cook, Katherine L; Wärri, Anni; Soto-Pantoja, David R et al. (2014) Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer. Clin Cancer Res 20:3222-32
Xiao, Junfeng; Zhao, Yi; Varghese, Rency S et al. (2014) Evaluation of metabolite biomarkers for hepatocellular carcinoma through stratified analysis by gender, race, and alcoholic cirrhosis. Cancer Epidemiol Biomarkers Prev 23:64-72
Gu, Jinghua; Wang, Xiao; Halakivi-Clarke, Leena et al. (2014) BADGE: a novel Bayesian model for accurate abundance quantification and differential analysis of RNA-Seq data. BMC Bioinformatics 15 Suppl 9:S6
Liu, Hanqing; Beck, Tim N; Golemis, Erica A et al. (2014) Integrating in silico resources to map a signaling network. Methods Mol Biol 1101:197-245
Heckler, Mary M; Thakor, Hemang; Schafer, Cara C et al. (2014) ERK/MAPK regulates ERR? expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer. FEBS J 281:2431-42

Showing the most recent 10 out of 36 publications